Sentiment-Signal
9,7
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Stammdaten
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.
Unternehmen & Branche
| Name | RadNet, Inc. |
|---|---|
| Ticker | RDNT |
| CIK | 0000790526 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Diagnostics & Research |
| SIC | 8071 · Services-Medical Laboratories |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 4,43 Mrd. USD |
| Beta | 1,53 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 2,040,210,000 | -18,652,000 | -0.25 | 3,758,563,000 | 1,089,890,000 |
| 2025-09-30 | 10-Q | 522,869,000 | 5,417,000 | 0.07 | 3,665,279,000 | 1,058,540,000 |
| 2025-06-30 | 10-Q | 498,230,000 | 14,454,000 | 0.19 | 3,514,966,000 | 932,314,000 |
| 2025-03-31 | 10-Q | 471,399,000 | -37,926,000 | -0.51 | 3,336,264,000 | 898,139,000 |
| 2024-12-31 | 10-K | 1,829,664,000 | 2,793,000 | 0.04 | 3,286,690,000 | 902,308,000 |
| 2024-09-30 | 10-Q | 461,142,000 | 3,209,000 | 0.04 | 3,275,342,000 | 895,313,000 |
| 2024-06-30 | 10-Q | 459,714,000 | -2,982,000 | -0.04 | 3,229,423,000 | 880,966,000 |
| 2024-03-31 | 10-Q | 431,707,000 | -2,779,000 | -0.04 | 2,969,555,000 | 872,955,000 |
| 2023-12-31 | 10-K | 1,616,630,000 | 3,044,000 | 0.05 | 2,690,473,000 | 630,695,000 |
| 2023-09-30 | 10-Q | 401,968,000 | 17,540,000 | 0.25 | 2,688,025,000 | 618,901,000 |
| 2023-06-30 | 10-Q | 403,715,000 | 8,369,000 | 0.12 | 2,705,290,000 | 593,159,000 |
| 2023-03-31 | 10-Q | 390,564,000 | -21,005,000 | -0.36 | 2,414,069,000 | 327,922,000 |
| 2022-12-31 | 10-K | 1,430,061,000 | 10,650,000 | 0.17 | 2,433,907,000 | 332,995,000 |
| 2022-09-30 | 10-Q | 350,044,000 | 668,000 | 0.01 | 2,247,164,000 | 313,006,000 |
| 2022-06-30 | 10-Q | 354,375,000 | 7,905,000 | 0.13 | 2,240,719,000 | 312,183,000 |
| 2022-03-31 | 10-Q | 341,767,000 | 3,013,000 | 0.05 | 2,141,521,000 | 298,847,000 |
| 2021-12-31 | 10-K | 1,315,077,000 | 24,727,000 | 0.46 | 2,058,474,000 | 228,904,000 |
| 2021-09-30 | 10-Q | 332,690,000 | 16,220,000 | 0.30 | 2,042,363,000 | 224,837,000 |
| 2021-06-30 | 10-Q | 333,918,000 | 2,873,000 | 0.05 | 2,032,198,000 | 197,064,000 |
| 2021-03-31 | 10-Q | 315,319,000 | 9,458,000 | 0.18 | 1,828,786,000 | 184,358,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-18 | Sorensen Alma Gregory | Director, Officer, Chief Strategy Officer | Open Market Sale | -14,200 | 62.12 | -882,104.00 | -78,1% | |
| 2026-03-18 | Sorensen Alma Gregory | Director, Officer, Chief Strategy Officer | Open Market Sale | -800 | 62.72 | -50,176.00 | -4,4% | |
| 2025-12-05 | Forthuber Stephen M | Officer, Pres & COO-Eastern Operations | Open Market Sale | -31,790 | 77.99 | -2,479,302.10 | -219,5% | |
| 2025-12-05 | Forthuber Stephen M | Officer, Pres & COO-Eastern Operations | Open Market Sale | -11,598 | 79.06 | -916,937.88 | -81,2% | |
| 2025-12-05 | Forthuber Stephen M | Officer, Pres & COO-Eastern Operations | Open Market Sale | -1,700 | 79.77 | -135,609.00 | -12,0% | |
| 2025-11-19 | Patel Mital | Officer, EVP of Fin Planning, CAO | Open Market Sale | -15,080 | 80.05 | -1,207,154.00 | -106,9% | |
| 2025-11-18 | Patel Mital | Officer, EVP of Fin Planning, CAO | Open Market Sale | -9,920 | 80.00 | -793,600.00 | -70,3% | |
| 2025-11-17 | Patel Mital | Officer, EVP of Fin Planning, CAO | Open Market Sale | -25,000 | 76.06 | -1,901,500.00 | -168,4% | |
| 2025-09-16 | Katz David Jeffrey | Officer, EVP and Chief Legal Officer | Open Market Sale | -14,000 | 74.44 | -1,042,160.00 | -92,3% | |
| 2025-09-16 | STOLPER MARK | Officer, EVP, Chief Financial Officer | Open Market Sale | -35,000 | 73.89 | -2,586,150.00 | -229,0% | |
| 2025-09-11 | Wesdorp Cornelis | Officer, Pres & CEO, Digital Health | Open Market Sale | -500 | 72.13 | -36,065.00 | -3,2% | |
| 2025-09-10 | HAMES NORMAN R | Officer, Pres and COO-West Operations | Open Market Sale | -10,000 | 72.74 | -727,400.00 | -64,4% | |
| 2025-09-09 | Wesdorp Cornelis | Officer, Pres & CEO, Digital Health | Open Market Sale | -500 | 71.99 | -35,995.00 | -3,2% | |
| 2025-08-27 | HAMES NORMAN R | Officer, Pres and COO-West Operations | Open Market Sale | -5,000 | 71.10 | -355,500.00 | -31,5% | |
| 2025-08-19 | Jayanathan Ranjan | Officer, Chief Information Officer | Open Market Sale | -65,598 | 67.50 | -4,427,865.00 | -392,0% | |
| 2025-08-19 | Wesdorp Cornelis | Officer, Pres & CEO, Digital Health | Open Market Sale | -1,500 | 66.98 | -100,470.00 | -8,9% | |
| 2025-08-13 | Katz David Jeffrey | Officer, EVP and Chief Legal Officer | Open Market Sale | -17,000 | 68.31 | -1,161,270.00 | -102,8% | |
| 2025-06-05 | Murdock Michael N | Officer, EVP, Mergers and Acquisitions | Open Market Sale | -11,132 | 58.05 | -646,212.60 | -57,2% | |
| 2025-05-23 | Sorensen Alma Gregory | Director, Officer, EVP, Chief Science Officer | Open Market Sale | -55,000 | 56.48 | -3,106,400.00 | -275,0% | |
| 2025-05-22 | Sorensen Alma Gregory | Director, Officer, EVP, Chief Science Officer | Open Market Sale | -45,000 | 57.06 | -2,567,700.00 | -227,3% | |
| 2025-05-16 | Levitt Lawrence L | Director | Open Market Sale | -5,000 | 61.09 | -305,450.00 | -27,0% | |
| 2025-05-16 | Forthuber Stephen M | Officer, Pres & COO-Eastern Operations | Open Market Sale | -18,820 | 60.34 | -1,135,598.80 | -100,5% | |
| 2025-05-15 | HAMES NORMAN R | Officer, Pres and COO-West Operations | Open Market Sale | -5,536 | 60.00 | -332,160.00 | -29,4% | |
| 2025-05-15 | HAMES NORMAN R | Officer, Pres and COO-West Operations | Open Market Sale | -2,911 | 60.00 | -174,660.00 | -15,5% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.